Cargando…
Interim estimates in null models of COVID-19 vaccine effectiveness
Recently released interim numbers from advanced vaccine candidate clinical trials suggest that a COVID-19 vaccine effectiveness (VE) of >90% is achievable. However, SARS-CoV-2 transmission dynamics are highly heterogeneous and exhibit localized bursts of transmission, which may lead to sharp loca...
Autor principal: | Lisewski, Andreas Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970752/ https://www.ncbi.nlm.nih.gov/pubmed/33746095 http://dx.doi.org/10.1016/j.ijid.2021.03.050 |
Ejemplares similares
-
Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings
por: Iwata, Satoshi, et al.
Publicado: (2022) -
Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis
por: Chopra, Arvind, et al.
Publicado: (2021) -
Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma
por: Kurch, Lars, et al.
Publicado: (2021) -
Interim estimates of the effectiveness of influenza vaccination against influenza‐associated hospitalization in children in Hong Kong, 2015–16
por: Cowling, Benjamin J., et al.
Publicado: (2016) -
Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18
por: Chiu, Susan S, et al.
Publicado: (2018)